Walter Lovenberg, Ph.D.
Acting Chief Executive Officer
Dr. Walter Lovenberg is Acting CEO of QuantumBio and serves on the Board of Directors. He is also currently President of Lovenberg Associates, Inc. and a director of Merrimack Pharmaceuticals, Inc. Previously, he was a Director of OSI Pharmaceuticals, Inc. ( 1993-2006) and former director of several private biotechnology companies. Some of Dr. Lovenberg’s past positions include Executive Vice President and Board member of Marion Merrell Dow, Inc. where he was responsible for global research. Additionally, he was previously Chief of the Section of Biochemical Pharmacology at the National Institutes of Health. Dr. Lovenberg received a Ph.D. from George Washington University and is the author or co-author of over 300 scientific publications.
Lance M. Westerhoff, Ph.D.
General Manager and Chief Software Engineer/Project Manager
Dr. Westerhoff is the General Manager and Chief Software Engineer/Project Manager. He is an Entrepreneur and Computational Biochemist whose experience includes project management and leadership; software engineering and development; strategic planning; and fund raising efforts including angel, venture capital, and public/grant funding sources. Scientifically accomplished through projects involving the synergistic application of quantum mechanics and molecular mechanics in the life and pharmaceutical sciences. Well accustomed to the small company environment and able to “wear many hats” in order to perform the duties required for successful research, development, and deployment of advanced technology. Able to interact with and manage scientists, engineers, and business people in various capacities including management, investors, customers, staff scientists, and academicians.
Kenneth M. Merz, Jr., Ph.D.
Chief Scientific Officer
Dr. Merz is the Chief Scientific Officer and serves on the Board of Directors. He is currently the Colonel Allan R. and Margaret G. Crow Term Professor of Chemistry at the University of Florida and a Member and Co-Director of the Quantum Theory Project. His research interest is in the application of theoretical and computational tools to biological problems including drug design, mechanistic enzymology and protein folding. Prior to his current position, Dr. Merz was an Assistant, Associate, and Professor of Chemistry at the Pennsylvania State University from 1989-2005. He also has worked in industry (1998-2001) as the Senior Director of the Center for Informatics and Drug Discovery (CIDD) at Pharmacopeia, Inc. and as the Senior Director of the ADMET Research and Development Group in the Accelrys software division of Pharmacopeia. Dr. Merz is a recognized leader in the field of computational chemistry, publishing over 150 articles in peer-reviewed journals and giving more than 150 presentations worldwide. He has received a number of honors including the 2010 ACS Award for Computers in Chemical and Pharmaceutical Research, election as a fellow of the American Association for the Advancement of Science, a John Simon Guggenheim Fellowship and he has held visiting professorships at the Institute for Research in Biomedicine (Barcelona, Spain), École Polytechnique (Paris, France), University of Florence (Florence, Italy), The University of Strasbourg (Strasbourg, France), The University of Oviedo (Oviedo, Spain) and the ETH (Zurich, Switzerland). He received his BS from Washington College and his Ph.D. in Organic Chemistry from The University of Texas.
Joel Westerhoff serves as the Treasurer of QuantumBio Inc. He has served as the company's outside accountant since September of 2005. He also is an entrepreneur by operating his own small tax and accounting business, JLW Business Services, in Ephrata, PA. Prior to joining QuantumBio, he was a licensed real estate agent for Prudential Homesale Services and Controller of Safeguard Products for a manufacturer in New Holland, PA for 25 years.